Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

2.45
+0.03001.24%
Post-market: 2.510.0600+2.45%16:00 EDT
Volume:9.34K
Turnover:22.93K
Market Cap:6.21M
PE:-0.35
High:2.58
Open:2.40
Low:2.34
Close:2.42
Loading ...
Aug 18, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 14, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 09, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Major Issues Report

8-K - Current report
Jun 19, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 29, 2020

Major Issues Report

8-K - Current report
May 18, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 15, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 16, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 14, 2019

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 26, 2019

Correspondence

CORRESP [Cover] - Correspondence
Sep 24, 2019

Major Issues Report

8-K - Current report
Sep 13, 2019

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Aug 23, 2019

Major Issues Report

8-K - Current report